Sustained-release Ophthalmology Product
An injectable sustained-release ophthalmology product incorporating DURECT’s SABER® depot technology. The active pharmaceutical ingredient and indication have not been disclosed.
- Reduced injection frequency
- Reduced overall risk of injection-associated complications, such as injury and infection
This product is in pre-clinical development.
There are risks and uncertainties associated with our business. Please see our most recent SEC filings (10-K or 10-Q) for a complete description of these risks and uncertainties, which are incorporated herein by reference.